Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 174 entries
Sorted by: Best Match Show Resources per page
Combined (1)H MRI, PET and Multinuclear MRS hybrid imaging system.

EJNMMI physics

Hankiewicz JH, Celinski Z, Smiley K, Majewski S.
PMID: 26501649
EJNMMI Phys. 2014 Jul;1:A6. doi: 10.1186/2197-7364-1-S1-A6.

No abstract available.

Cite
Hankiewicz JH, Celinski Z, Smiley K, et al. Combined (1)H MRI, PET and Multinuclear MRS hybrid imaging system. EJNMMI Phys. 2014;1:A6doi: 10.1186/2197-7364-1-S1-A6.
Hankiewicz, J. H., Celinski, Z., Smiley, K., & Majewski, S. (2014). Combined (1)H MRI, PET and Multinuclear MRS hybrid imaging system. EJNMMI physics, 1A6. https://doi.org/10.1186/2197-7364-1-S1-A6
Hankiewicz, Janusz H, et al. "Combined (1)H MRI, PET and Multinuclear MRS hybrid imaging system." EJNMMI physics vol. 1 (2014): A6. doi: https://doi.org/10.1186/2197-7364-1-S1-A6
Hankiewicz JH, Celinski Z, Smiley K, Majewski S. Combined (1)H MRI, PET and Multinuclear MRS hybrid imaging system. EJNMMI Phys. 2014 Jul;1:A6. doi: 10.1186/2197-7364-1-S1-A6. PMID: 26501649; PMCID: PMC4546059.
Copy Download .nbib Format: NLM
Unresectable Pancreatic Adenocarcinoma: Eight Years Later.

World journal of oncology

Smiley K, Malhotra R, Peche W, Langell JT.
PMID: 28983358
World J Oncol. 2016 Feb;7(1):17-20. doi: 10.14740/wjon957w. Epub 2016 Apr 03.

Pancreatic cancer is the fourth leading cause of cancer deaths in the United States, and is considered uniformly fatal when patients present with unresectable, advanced-stage disease at the time of diagnosis. Long-term survival of patients with advanced-stage pancreatic adenocarcinoma...

Cite
Smiley K, Malhotra R, Peche W, et al. Unresectable Pancreatic Adenocarcinoma: Eight Years Later. World J Oncol. 2016;7(1):17-20doi: 10.14740/wjon957w.
Smiley, K., Malhotra, R., Peche, W., & Langell, J. T. (2016). Unresectable Pancreatic Adenocarcinoma: Eight Years Later. World journal of oncology, 7(1), 17-20. https://doi.org/10.14740/wjon957w
Smiley, Kate, et al. "Unresectable Pancreatic Adenocarcinoma: Eight Years Later." World journal of oncology vol. 7,1 (2016): 17-20. doi: https://doi.org/10.14740/wjon957w
Smiley K, Malhotra R, Peche W, Langell JT. Unresectable Pancreatic Adenocarcinoma: Eight Years Later. World J Oncol. 2016 Feb;7(1):17-20. doi: 10.14740/wjon957w. Epub 2016 Apr 03. PMID: 28983358; PMCID: PMC5624684.
Copy Download .nbib Format: NLM
Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors.

ACS medicinal chemistry letters

Bogen SL, Pan W, Gibeau CR, Lahue BR, Ma Y, Nair LG, Seigel E, Shipps GW, Tian Y, Wang Y, Lin Y, Liu M, Liu S, Mirza A, Wang X, Lipari P, Seidel-Dugan C, Hicklin DJ, Bishop WR, Rindgen D, Nomeir A, Prosise W, Reichert P, Scapin G, Strickland C, Doll RJ.
PMID: 26985323
ACS Med Chem Lett. 2016 Jan 20;7(3):324-9. doi: 10.1021/acsmedchemlett.5b00472. eCollection 2016 Mar 10.

A new subseries of substituted piperidines as p53-HDM2 inhibitors exemplified by 21 has been developed from the initial lead 1. Research focused on optimization of a crucial HDM2 Trp23-ligand interaction led to the identification of 2-(trifluoromethyl)thiophene as the preferred...

Cite
Bogen SL, Pan W, Gibeau CR, et al. Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors. ACS Med Chem Lett. 2016;7(3):324-9doi: 10.1021/acsmedchemlett.5b00472.
Bogen, S. L., Pan, W., Gibeau, C. R., Lahue, B. R., Ma, Y., Nair, L. G., Seigel, E., Shipps, G. W., Tian, Y., Wang, Y., Lin, Y., Liu, M., Liu, S., Mirza, A., Wang, X., Lipari, P., Seidel-Dugan, C., Hicklin, D. J., Bishop, W. R., Rindgen, D., Nomeir, A., Prosise, W., Reichert, P., Scapin, G., Strickland, C., & Doll, R. J. (2016). Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors. ACS medicinal chemistry letters, 7(3), 324-9. https://doi.org/10.1021/acsmedchemlett.5b00472
Bogen, Stéphane L, et al. "Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors." ACS medicinal chemistry letters vol. 7,3 (2016): 324-9. doi: https://doi.org/10.1021/acsmedchemlett.5b00472
Bogen SL, Pan W, Gibeau CR, Lahue BR, Ma Y, Nair LG, Seigel E, Shipps GW, Tian Y, Wang Y, Lin Y, Liu M, Liu S, Mirza A, Wang X, Lipari P, Seidel-Dugan C, Hicklin DJ, Bishop WR, Rindgen D, Nomeir A, Prosise W, Reichert P, Scapin G, Strickland C, Doll RJ. Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 Inhibitors. ACS Med Chem Lett. 2016 Jan 20;7(3):324-9. doi: 10.1021/acsmedchemlett.5b00472. eCollection 2016 Mar 10. PMID: 26985323; PMCID: PMC4789661.
Copy Download .nbib Format: NLM
Tb.

Frontiers in chemistry

Choudhary PK, Gallo S, Sigel RK.
PMID: 28377919
Front Chem. 2017 Mar 21;5:10. doi: 10.3389/fchem.2017.00010. eCollection 2017.

Riboswitches are RNA elements that bind specific metabolites in order to regulate the gene expression involved in controlling the cellular concentration of the respective molecule or ion. Ligand recognition is mostly facilitated by Mg

Cite
Choudhary PK, Gallo S, Sigel RK. Tb. Front Chem. 2017;5:10doi: 10.3389/fchem.2017.00010.
Choudhary, P. K., Gallo, S., & Sigel, R. K. (2017). Tb. Frontiers in chemistry, 510. https://doi.org/10.3389/fchem.2017.00010
Choudhary, Pallavi K, et al. "Tb." Frontiers in chemistry vol. 5 (2017): 10. doi: https://doi.org/10.3389/fchem.2017.00010
Choudhary PK, Gallo S, Sigel RK. Tb. Front Chem. 2017 Mar 21;5:10. doi: 10.3389/fchem.2017.00010. eCollection 2017. PMID: 28377919; PMCID: PMC5359240.
Copy Download .nbib Format: NLM
Prolactin secretion during sleep in obstructive sleep apnoea patients.

Journal of sleep research

Spiegel K, Follenius M, Krieger J, Sforza E, Brandenberger G.
PMID: 10607142
J Sleep Res. 1995 Mar;4(1):56-62. doi: 10.1111/j.1365-2869.1995.tb00151.x.

Plasma prolactin (PRL) concentration exhibits a sleep-dependent pattern, with highest levels during sleep and lowest levels during the waking period. The syndrome of obstructive sleep apnoea (OSA) is associated with severe hypoxaemia and chronic sleep fragmentation, both of which...

Cite
Spiegel K, Follenius M, Krieger J, et al. Prolactin secretion during sleep in obstructive sleep apnoea patients. J Sleep Res. 1995;4(1):56-62doi: 10.1111/j.1365-2869.1995.tb00151.x.
Spiegel, K., Follenius, M., Krieger, J., Sforza, E., & Brandenberger, G. (1995). Prolactin secretion during sleep in obstructive sleep apnoea patients. Journal of sleep research, 4(1), 56-62. https://doi.org/10.1111/j.1365-2869.1995.tb00151.x
Spiegel, et al. "Prolactin secretion during sleep in obstructive sleep apnoea patients." Journal of sleep research vol. 4,1 (1995): 56-62. doi: https://doi.org/10.1111/j.1365-2869.1995.tb00151.x
Spiegel K, Follenius M, Krieger J, Sforza E, Brandenberger G. Prolactin secretion during sleep in obstructive sleep apnoea patients. J Sleep Res. 1995 Mar;4(1):56-62. doi: 10.1111/j.1365-2869.1995.tb00151.x. PMID: 10607142.
Copy Download .nbib Format: NLM
[Various hole sizes in roentgen grid therapy].

Strahlentherapie

SEIDEL K.
PMID: 13433091
Strahlentherapie. 1957;102(1):109-11.

No abstract available.

Cite
SEIDEL K. Uber verschiedene Lochgrossen bei Röntgensiebbestrahlung. [Various hole sizes in roentgen grid therapy]. Strahlentherapie. 1957;102(1):109-11
SEIDEL, K. (1957). Uber verschiedene Lochgrossen bei Röntgensiebbestrahlung. [Various hole sizes in roentgen grid therapy]. Strahlentherapie, 102(1), 109-11.
SEIDEL, K. "Uber verschiedene Lochgrossen bei Röntgensiebbestrahlung." [Various hole sizes in roentgen grid therapy]. Strahlentherapie vol. 102,1 (1957): 109-11.
SEIDEL K. Uber verschiedene Lochgrossen bei Röntgensiebbestrahlung. [Various hole sizes in roentgen grid therapy]. Strahlentherapie. 1957;102(1):109-11. German. PMID: 13433091.
Copy Download .nbib Format: NLM
[Deep doses in grid irradiation].

Strahlentherapie

SEIDEL K.
PMID: 13337561
Strahlentherapie. 1956;99(4):549-54.

No abstract available.

Cite
SEIDEL K. Tiefendosen bei Röntgensiebbestrahlung. [Deep doses in grid irradiation]. Strahlentherapie. 1956;99(4):549-54
SEIDEL, K. (1956). Tiefendosen bei Röntgensiebbestrahlung. [Deep doses in grid irradiation]. Strahlentherapie, 99(4), 549-54.
SEIDEL, K. "Tiefendosen bei Röntgensiebbestrahlung." [Deep doses in grid irradiation]. Strahlentherapie vol. 99,4 (1956): 549-54.
SEIDEL K. Tiefendosen bei Röntgensiebbestrahlung. [Deep doses in grid irradiation]. Strahlentherapie. 1956;99(4):549-54. German. PMID: 13337561.
Copy Download .nbib Format: NLM
Global interest in addressing non-communicable disease.

Lancet (London, England)

Stevens D, Siegel K, Smith R.
PMID: 18068503
Lancet. 2007 Dec 08;370(9603):1901-2. doi: 10.1016/S0140-6736(07)61802-9.

No abstract available.

Cite
Stevens D, Siegel K, Smith R. Global interest in addressing non-communicable disease. Lancet. 2007;370(9603):1901-2doi: 10.1016/S0140-6736(07)61802-9.
Stevens, D., Siegel, K., & Smith, R. (2007). Global interest in addressing non-communicable disease. Lancet (London, England), 370(9603), 1901-2. https://doi.org/10.1016/S0140-6736(07)61802-9
Stevens, Denise, et al. "Global interest in addressing non-communicable disease." Lancet (London, England) vol. 370,9603 (2007): 1901-2. doi: https://doi.org/10.1016/S0140-6736(07)61802-9
Stevens D, Siegel K, Smith R. Global interest in addressing non-communicable disease. Lancet. 2007 Dec 08;370(9603):1901-2. doi: 10.1016/S0140-6736(07)61802-9. PMID: 18068503.
Copy Download .nbib Format: NLM
The effects of individual and group consequences on school attendance and curfew violations with predelinquent adolescents.

Journal of applied behavior analysis

Alexander RN, Corbett TF, Smigel J.
PMID: 16795523
J Appl Behav Anal. 1976;9(2):221-6. doi: 10.1901/jaba.1976.9-221.

No abstract available.

Cite
Alexander RN, Corbett TF, Smigel J. The effects of individual and group consequences on school attendance and curfew violations with predelinquent adolescents. J Appl Behav Anal. 1976;9(2):221-6doi: 10.1901/jaba.1976.9-221.
Alexander, R. N., Corbett, T. F., & Smigel, J. (1976). The effects of individual and group consequences on school attendance and curfew violations with predelinquent adolescents. Journal of applied behavior analysis, 9(2), 221-6. https://doi.org/10.1901/jaba.1976.9-221
Alexander, R N, et al. "The effects of individual and group consequences on school attendance and curfew violations with predelinquent adolescents." Journal of applied behavior analysis vol. 9,2 (1976): 221-6. doi: https://doi.org/10.1901/jaba.1976.9-221
Alexander RN, Corbett TF, Smigel J. The effects of individual and group consequences on school attendance and curfew violations with predelinquent adolescents. J Appl Behav Anal. 1976;9(2):221-6. doi: 10.1901/jaba.1976.9-221. PMID: 16795523; PMCID: PMC1311931.
Copy Download .nbib Format: NLM
Sexual Risk Behaviors with Female and Male Partners Met in Different Sexual Venues Among Non-Gay-Identified, Non-Disclosing MSMW.

International journal of sexual health : official journal of the World Association for Sexual Health

Schrimshaw EW, Siegel K, Downing MJ.
PMID: 22059106
Int J Sex Health. 2010;22(3):167-179. doi: 10.1080/19317611003748821.

Despite considerable interest in the sexual behavior of non-disclosing men who have sex with men and women (MSMW), little is known about where they meet their male and female partners and whether their sexual risk behavior differs with partners...

Cite
Schrimshaw EW, Siegel K, Downing MJ. Sexual Risk Behaviors with Female and Male Partners Met in Different Sexual Venues Among Non-Gay-Identified, Non-Disclosing MSMW. Int J Sex Health. 2010;22(3):167-179doi: 10.1080/19317611003748821.
Schrimshaw, E. W., Siegel, K., & Downing, M. J. (2010). Sexual Risk Behaviors with Female and Male Partners Met in Different Sexual Venues Among Non-Gay-Identified, Non-Disclosing MSMW. International journal of sexual health : official journal of the World Association for Sexual Health, 22(3), 167-179. https://doi.org/10.1080/19317611003748821
Schrimshaw, Eric W, et al. "Sexual Risk Behaviors with Female and Male Partners Met in Different Sexual Venues Among Non-Gay-Identified, Non-Disclosing MSMW." International journal of sexual health : official journal of the World Association for Sexual Health vol. 22,3 (2010): 167-179. doi: https://doi.org/10.1080/19317611003748821
Schrimshaw EW, Siegel K, Downing MJ. Sexual Risk Behaviors with Female and Male Partners Met in Different Sexual Venues Among Non-Gay-Identified, Non-Disclosing MSMW. Int J Sex Health. 2010;22(3):167-179. doi: 10.1080/19317611003748821. PMID: 22059106; PMCID: PMC3206637.
Copy Download .nbib Format: NLM
Concurrent radiotherapy with Carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma.

Frontiers in oncology

Saigal K, Santos ES, Tolba K, Kwon D, Elsayyad N, Abramowitz MC, Mandalia A, Samuels MA.
PMID: 25072020
Front Oncol. 2014 Jun 30;4:165. doi: 10.3389/fonc.2014.00165. eCollection 2014.

BACKGROUND: Cetuximab (Cx) + radiation therapy (RT) is well-tolerated and has improved survival in patients (pts) with locoregionally advanced head and neck squamous cell carcinomas (LA-HNSCC). However, its efficacy when compared to HD-DDP + RT has been questioned. At...

Cite
Saigal K, Santos ES, Tolba K, et al. Concurrent radiotherapy with Carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma. Front Oncol. 2014;4:165doi: 10.3389/fonc.2014.00165.
Saigal, K., Santos, E. S., Tolba, K., Kwon, D., Elsayyad, N., Abramowitz, M. C., Mandalia, A., & Samuels, M. A. (2014). Concurrent radiotherapy with Carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma. Frontiers in oncology, 4165. https://doi.org/10.3389/fonc.2014.00165
Saigal, Kunal, et al. "Concurrent radiotherapy with Carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma." Frontiers in oncology vol. 4 (2014): 165. doi: https://doi.org/10.3389/fonc.2014.00165
Saigal K, Santos ES, Tolba K, Kwon D, Elsayyad N, Abramowitz MC, Mandalia A, Samuels MA. Concurrent radiotherapy with Carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma. Front Oncol. 2014 Jun 30;4:165. doi: 10.3389/fonc.2014.00165. eCollection 2014. PMID: 25072020; PMCID: PMC4074875.
Copy Download .nbib Format: NLM
Downregulation of FGF Signaling by .

JBMR plus

Marangoni P, Charles C, Ahn Y, Seidel K, Jheon A, Ganss B, Krumlauf R, Viriot L, Klein OD.
PMID: 31485553
JBMR Plus. 2019 Jul 31;3(8):e10205. doi: 10.1002/jbm4.10205. eCollection 2019 Aug.

FGF signaling plays a critical role in tooth development, and mutations in modulators of this pathway produce a number of striking phenotypes. However, many aspects of the role of the FGF pathway in regulating the morphological features and the...

Cite
Marangoni P, Charles C, Ahn Y, et al. Downregulation of FGF Signaling by . JBMR Plus. 2019;3(8):e10205doi: 10.1002/jbm4.10205.
Marangoni, P., Charles, C., Ahn, Y., Seidel, K., Jheon, A., Ganss, B., Krumlauf, R., Viriot, L., & Klein, O. D. (2019). Downregulation of FGF Signaling by . JBMR plus, 3(8), e10205. https://doi.org/10.1002/jbm4.10205
Marangoni, Pauline, et al. "Downregulation of FGF Signaling by ." JBMR plus vol. 3,8 (2019): e10205. doi: https://doi.org/10.1002/jbm4.10205
Marangoni P, Charles C, Ahn Y, Seidel K, Jheon A, Ganss B, Krumlauf R, Viriot L, Klein OD. Downregulation of FGF Signaling by . JBMR Plus. 2019 Jul 31;3(8):e10205. doi: 10.1002/jbm4.10205. eCollection 2019 Aug. PMID: 31485553; PMCID: PMC6715786.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 174 entries